MedLife invests EUR 3 million in genetic testing, becoming a leader in personalized medicine in Romania with the aim to improve quality of life.
Delia Niculescu
Current Affairs
foto:shutterstock
Always see our news on Google
MedLife is to launch an innovative genetic testing program, with an initial investment of €3 million, aimed at facilitating access to individual genetic mapping and promoting personalized medicine. The project will involve over 4,000 beneficiaries and will use Illumina NovaSeq X Plus sequencing technology, one of the most advanced in the world. This initiative marks an important transition in the Romanian medical system, aiming at prevention and personalization of treatments according to genetic profile. MedLife, with more than 20 years of experience in genetics, thus confirms its leading role in the field and its commitment to improve the health of the population.
Sources
Premieră în România. MedLife aduce cea mai avansată tehnologie de secvențiere și pregătește un program amplu de testare genetică: “Începând cu luna octombrie, pe teritoriul României se va putea realiza secvențierea întregului genom uman la scară largă”
Secvențierea întregului genom uman la scară largă se va putea face în România, din octombrie - Economica.net
Latest News
13:56
VIDEO First images of the sunken ship after it was hit by a drone
13:51
Călin Georgescu remains in pretrial detention. The Bucharest Court of Appeal admitted DIICOT's appeal.
13:44
The Presidential Administration classified the $3.39 million lobbying contract with Eversheds
13:43
Dan Neculăescu condemns the new attack in the Black Sea: It represents a flagrant violation of international law and freedom of navigation
13:42
A teenage girl is accused of poisoning Ukrainian soldiers on behalf of Russia, causing the deaths of two servicemen / How much the FSB promised her for the operation
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
